相关实验视频

Updated: Jul 3, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

评估CAIX和ProEx-C在部状内皮病变中的诊断价值

Aslı Kahraman¹, Fikret Dirilenoğlu²

¹Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Türkiye.

Pathology, research and practice

|December 20, 2023

概括

碳胺酶IX (CAIX) 和ProEx-C是检测子宫皮状内皮病变 (SILs) 的有希望的生物标志物. 它们的联合使用可以显著提高检测灵敏度,同时保持高特异性.

科学领域:

妇科病理学妇科病理学
瘤生物标志物瘤生物标志物
免疫组织化学免疫组织化学

背景情况:

宫状皮内皮病变 (SILs) 由于与良性疾病的形态相似性,造成了诊断上的挑战.
解释的可变性需要客观的生物标志物来准确识别和分类SIL.

研究的目的:

评估免疫组织化学标志物的诊断实用性碳酸无水素IX (CAIX) 和ProEx-C在宫SIL中.
评估CAIX和ProEx-C用于检测和分类SIL的灵敏度和特异性.

主要方法:

追溯分析56个SIL病例 (20个LSIL,36个HSIL) 和9个慢性宫炎对照.
用CAIX和ProEx-C在甲固定,嵌组织上进行免疫组织化学染色.
对SIL检测和分级的标记器灵敏度和特异性的评估.

主要成果:

在SIL检测中,CAIX显示了64.3%的灵敏度和100%的特异性.
在SIL检测中,ProEx-C显示了66.1%的灵敏度和100%的特异性.
联合CAIX和ProEx-C使灵敏度增加到80.4%,但没有影响特异性;两种标记都没有将LSIL与HSIL区分开来.

结论:

CAIX和ProEx-C是检测宫SIL具有高灵敏度和特异性的有价值的免疫组织化学标志物.
CAIX和ProEx-C的组合可以提高SIL检测率.
需要进一步的研究来探索它们在宫癌发生和HPV感染中的作用.

关键词:

CAIXIX CAIXIX 这是一个很好的例子.宫的子宫可以这是ProEx-C.状上皮内皮病变的病变

更多相关视频

Merkel Cell Polyomavirus Infection and Detection

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

相关概念视频

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...